Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Drugs

Showing results (251-260 of 8,370) with videos related to

Pageof 837
Sort By:
Drugs|July 12, 2002
The epidemiology of smoking: health consequences and benefits of cessationKarl Fagerström
Drugs|August 1, 2002
Who should receive HMG CoA reductase inhibitors?Koon K Teo, Jeffrey R Burton
Drugs|September 7, 2002
Management of bacterial urinary tract infections in adult patients with diabetes mellitusRuby Meiland, Suzanne E Geerlings, Andy I M Hoepelman
Drugs|September 7, 2002
Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?Teri Pearlstein
Drugs|September 7, 2002
Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemiaGillian M Keating, Douglas Ormrod
Drugs|July 31, 2003
Tenofovir disoproxil fumarateAnil Kumar
Drugs|December 1, 1992
Current status of phosphodiesterase inhibitors in the treatment of congestive heart failureT A Fischer, R Erbel, N Treese
Drugs|December 1, 1992
Disseminated intravascular coagulation. Approach to treatmentR N Rubin, R W Colman
Drugs|October 1, 1992
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectorisJ Frampton, M M Buckley, A Fitton
Drugs|October 1, 1992
Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS)R Whittington, R N Brogden
Pageof 837

Showing results (251-260 of 8,370) with videos related to

Sort By:
Pageof 837
Drugs|July 12, 2002
The epidemiology of smoking: health consequences and benefits of cessationKarl Fagerström
Drugs|August 1, 2002
Who should receive HMG CoA reductase inhibitors?Koon K Teo, Jeffrey R Burton
Drugs|September 7, 2002
Management of bacterial urinary tract infections in adult patients with diabetes mellitusRuby Meiland, Suzanne E Geerlings, Andy I M Hoepelman
Drugs|September 7, 2002
Selective serotonin reuptake inhibitors for premenstrual dysphoric disorder: the emerging gold standard?Teri Pearlstein
Drugs|September 7, 2002
Micronised fenofibrate: an updated review of its clinical efficacy in the management of dyslipidaemiaGillian M Keating, Douglas Ormrod
Drugs|July 31, 2003
Tenofovir disoproxil fumarateAnil Kumar
Drugs|December 1, 1992
Current status of phosphodiesterase inhibitors in the treatment of congestive heart failureT A Fischer, R Erbel, N Treese
Drugs|December 1, 1992
Disseminated intravascular coagulation. Approach to treatmentR N Rubin, R W Colman
Drugs|October 1, 1992
Nicorandil. A review of its pharmacology and therapeutic efficacy in angina pectorisJ Frampton, M M Buckley, A Fitton
Drugs|October 1, 1992
Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS)R Whittington, R N Brogden
Pageof 837